Muneyuki Sekiya Selected Research

Therapeutics

10/2023	Entrectinib-induced syndrome of inappropriate antidiuretic hormone secretion in a patient with ROS1-rearranged non-small cell lung cancer.
11/2017	Fatal diffuse alveolar haemorrhage mimicking acute exacerbation in idiopathic pulmonary fibrosis treated with nintedanib.
1/2017	Miliary Tuberculosis that Developed after Intravesical Bacillus Calmette-Guerin Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Muneyuki Sekiya Research Topics

Disease

2	Lung Neoplasms (Lung Cancer) 03/2024 - 07/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 07/2021
2	Trichosporonosis 09/2023 - 11/2020
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 09/2023 - 11/2020
2	Idiopathic Pulmonary Fibrosis 11/2017 - 01/2017
1	Adenocarcinoma of Lung 03/2024
1	Brain Neoplasms (Brain Tumor) 03/2024
1	Systemic Vasculitis 10/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2023
1	Microscopic Polyangiitis 10/2023
1	Inappropriate ADH Syndrome (SIADH) 10/2023
1	Dizziness (Lightheadedness) 10/2023
1	Fatigue 10/2023
1	Hyponatremia 10/2023
1	Eosinophilia 01/2023
1	Invasive Pulmonary Aspergillosis 01/2023
1	Circulating Neoplastic Cells 07/2021
1	Thrombosis (Thrombus) 11/2017
1	Miliary Tuberculosis 01/2017
1	Granuloma 01/2017
1	Transitional Cell Carcinoma 01/2017
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2017

Drug/Important Bio-Agent (IBA)

2	pirfenidoneIBA 11/2017 - 01/2017
1	olaparibIBA 03/2024
1	Carcinoembryonic AntigenIBA 03/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2024
1	Carboplatin (JM8)FDA LinkGeneric 03/2024
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2023
1	entrectinibIBA 10/2023
1	SodiumIBA 10/2023
1	Vasopressins (Vasopressin)IBA 10/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	osimertinibIBA 07/2021
1	Messenger RNA (mRNA)IBA 07/2021
1	ErbB Receptors (EGF Receptor)IBA 07/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2017
1	Acetylcysteine (Siran)FDA LinkGeneric 11/2017
1	nintedanibIBA 11/2017
1	AcidsIBA 01/2017
1	ThrombomodulinIBA 01/2017

Therapy/Procedure

3	Therapeutics 10/2023 - 01/2017
2	Humidifiers 09/2023 - 11/2020
1	Radiotherapy 03/2024
1	Intravesical Administration 01/2017